Cargando…
Gender and Advanced Urothelial Cancer: Outcome, Efficacy and Toxicity following Chemotherapy
Background and Objectives: The incidence of urothelial cancer in males is higher than in females; however, females have a higher risk of recurrence and progression. The aim of our study was to report the effect of gender on the oncological outcome in advanced urothelial cancer. Materials and Methods...
Autores principales: | Becattini, Lucrezia, Saieva, Calogero, Doni, Laura, Roviello, Giandomenico, Spatafora, Pietro, Catalano, Martina, Sessa, Francesco, Galli, Ilaria Camilla, Bisegna, Claudio, Conte, Francesco Lupo, Zaccaro, Claudia, Santi, Raffaella, Serni, Sergio, Nesi, Gabriella, Villari, Donata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318271/ https://www.ncbi.nlm.nih.gov/pubmed/35888605 http://dx.doi.org/10.3390/medicina58070886 |
Ejemplares similares
-
Inflammation in Urological Malignancies: The Silent Killer
por: Catalano, Martina, et al.
Publicado: (2023) -
Prostate Cancer Characteristics in Renal Transplant Recipients: A 25-Year Experience From a Single Centre
por: Spatafora, Pietro, et al.
Publicado: (2021) -
Immune Checkpoint Inhibitors in Urothelial Bladder Cancer: State of the Art and Future Perspectives
por: Roviello, Giandomenico, et al.
Publicado: (2021) -
Adjuvant Therapy for Renal Cell Carcinoma: Hype or Hope?
por: Cosso, Federica, et al.
Publicado: (2023) -
Immune checkpoint inhibitor induced nephrotoxicity: An ongoing challenge
por: Catalano, Martina, et al.
Publicado: (2022)